Genentech Becomes First Early-Access Partner for WaferGen Single-Cell Tech | GenomeWeb

NEW YORK (GenomeWeb) – WaferGen Bio-systems announced today that it has signed a deal to work with Roche subsidiary Genentech to evaluate and test its SmartChip platform in single-cell sequencing as part of an early-access program.

WaferGen said the companies will validate the SmartChip technology for isolating single cells from various tissues and preparing libraries for next-generation sequencing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.